This HTML5 document contains 72 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64645645
rdf:type
wikibase:Item
schema:description
clinical trial клінічне випробування klinisch onderzoek ensayu clínicu
rdfs:label
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
skos:prefLabel
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
schema:name
Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin
p:P1476
wds:Q64645645-1581B0F4-B8CC-4684-B5F2-BE0514940614
wdt:P1476
A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose-ranging, Parallel Group Study To Evaluate Safety And Efficacy Of Pf-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
p:P582
wds:Q64645645-0848A7A9-CA32-443A-8133-5F2DF941C956
wdt:P582
2013-01-01T00:00:00Z
p:P31
wds:Q64645645-B206568B-4F46-4830-A11C-5D2813728AB4
wdt:P31
wd:Q30612
p:P580
wds:Q64645645-22AA3381-E36C-4297-9F86-CF05DFA875B2
wdt:P580
2012-02-01T00:00:00Z
p:P17
wds:Q64645645-256C70D9-6F4A-49AE-ACB9-1A0DA5E6D309 wds:Q64645645-B887EC64-D305-4A00-BE6E-98587B2698A2 wds:Q64645645-727234A4-44EE-4320-9066-D3C752F9050C wds:Q64645645-AD192FE4-5478-4B13-88D6-A53E4DB31C78 wds:Q64645645-3C3EF924-861F-4D08-B989-7BA65355DE7D wds:Q64645645-6C12C0A7-8D79-4EE3-B45A-0318C28BE599 wds:Q64645645-2B60C218-3EC0-4ADD-BE75-FA6BF746849D
wdt:P17
wd:Q668 wd:Q865 wd:Q219 wd:Q30 wd:Q214 wd:Q16 wd:Q28
p:P6153
wds:Q64645645-D2C38251-3D64-48CB-BCE8-DB94F761624F wds:Q64645645-6872BE68-074B-433F-B6B7-87F99D13D86A wds:Q64645645-3DB32128-D29C-4048-8E90-D2F6318CAC66 wds:Q64645645-A7FE4948-DFB8-4E73-B810-70E237E2466B wds:Q64645645-AD376215-8CA8-48AC-809C-86009F585B95 wds:Q64645645-6D608E33-0C69-42E8-9550-DE008B9A2602 wds:Q64645645-2648DF87-4D0F-4A09-BCD2-1FB379E23833 wds:Q64645645-01F919E5-63A9-4048-BB3A-A4C5AFC6726D wds:Q64645645-03AB27C6-1AF9-40B7-83EF-592D9EC7CD78 wds:Q64645645-F6936665-C152-4E22-B572-4DAA81BB8D5E wds:Q64645645-F6CE6808-D741-4B7C-9787-F7515CA60FFA wds:Q64645645-FF115513-6A06-4381-9E2B-03BF81A0D6B8
wdt:P6153
wd:Q30254282 wd:Q30269699 wd:Q30270068 wd:Q701818 wd:Q30269845 wd:Q30269657 wd:Q1418766 wd:Q706177 wd:Q30282209 wd:Q14956851 wd:Q30270131 wd:Q30269704
p:P4844
wds:Q64645645-4B77C34A-C7FF-4C20-BD5B-A79B39BE3CAD wds:Q64645645-906304BB-39BF-415B-9536-E78188D4DB0E
wdt:P4844
wd:Q425027 wd:Q19484
p:P2899
wds:Q64645645-89A93E25-5D70-45FE-ACF0-E8BCE4B1A40D
wdt:P2899
18
p:P1050
wds:Q64645645-7AB424D4-A03F-43E8-8102-BBC8DAA0EEC2
wdt:P1050
wd:Q12206
p:P1132
wds:Q64645645-3BEA32A8-CCBB-4094-ABBC-DF9608D3DEFF
wdt:P1132
304
p:P4135
wds:Q64645645-FA197DF0-BE21-47CF-8DCE-CBF55B0164AB
wdt:P4135
70
p:P8363
wds:Q64645645-50AC6F86-8B21-4683-88AC-0DB7566363BF
wdt:P8363
wd:Q78089383
p:P3098
wds:Q64645645-503C2529-7289-48AE-A03F-3F1A8BDA2DD6
wdt:P3098
NCT01517373
p:P6099
wds:Q64645645-E16F8E98-190A-4652-BC4F-6E5EF6DC398F
wdt:P6099
wd:Q42824440